Results 31 to 40 of about 41,660 (152)
Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma
Journal of Hepatocellular Carcinoma, 2014 Hui-Tzu Hsu,1 Chin-Wen Chi1,21Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan; 2Department of Medical Research, Taipei Veterans General Hospital, Taipei, TaiwanAbstract: Hepatocellular carcinoma
Hsu HT, Chi CW
doaj
Soy milk and ginger (Sulehe) increase PPAR-γ expression in a rat model of insulin resistance
Сахарный диабет, 2018 Background: Diabetes mellitus type 2 is metabolic disease characterized by hyperglycemia due to a defect in insulin secretion resulting in insulin resistance. This disease leads to dysfunction of various organs including eyes, kidneys, and heart.
Wiwik Handayani +3 more
doaj +1 more source
Effects Of PPARγ2 Pro12Ala Variant On Adipocyte Phenotype Dependent Of DHA
Diabetes, Metabolic Syndrome and Obesity, 2019 Renhui Wan,* Zhengping Ding,* Sheng Xia, Longyi Zheng, Jin Lu Department of Endocrinology, Changhai Hospital, Second Military Medical University, Shanghai 200433, People’s Republic of China*These authors contributed equally to this ...
Wan R, Ding Z, Xia S, Zheng L, Lu J
doaj
Frontiers in Physiology, 2017 Gliomas cells are the site of numerous metabolic and thermodynamics abnormalities with an increasing entropy rate which is characteristic of irreversible processes driven by changes in Gibbs energy, heat production, intracellular acidity, membrane ...
Alexandre Vallée +5 more
doaj +1 more source
PPAR gamma, bioactive lipids, and cancer progression [PDF]
Frontiers in Bioscience, 2012 In this article we review the evolution of cancer research involving PPARgamma, including mechanisms, target genes, and clinical applications. For the last thirteen years, the effects of PPARgamma activity on tumor biology have been studied intensely. Most of this research has focused upon the potential for employing agonists of this nuclear receptor ...
Gregory T, Robbins, Daotai, Nie
openaire +2 more sources
Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol
Cardiovascular Diabetology, 2010 Background Hyperhomocysteinemia (HHcy) and hyperglycemia cause diabetic cardiomyopathy by inducing oxidative stress and attenuating peroxisome proliferator- activated receptor (PPAR) gamma. However, their synergistic contribution is not clear.
Mishra Paras K +4 more
doaj +1 more source
Synthesis and Biological Activity of Piperine Derivatives as Potential PPARγ Agonists
Drug Design, Development and Therapy, 2020 Yanli Wang,1– 3 Yuan Yao,4,5 Jing Liu,2,6 Lili Wu,7 Tonghua Liu,7 Jian Cui,1 David Yue-Wei Lee2 1School of Pharmacy, Minzu University of China, Beijing 100081, People’s Republic of China; 2Bio-Organic and Natural Products Laboratory, McLean ...
Wang Y +6 more
doaj
Synthesis, activity, and docking study of phenylthiazole acids as potential agonists of PPARγ
Drug Design, Development and Therapy, 2016 Liang Ma,1,* Taijin Wang,2,* Min Shi,1 Haoyu Ye2 1Department of Nephrology, Kidney Research Institute, 2State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy, West China Hospital, West China Medical School of
Ma L, Wang T, Shi M, Ye H
doaj
Lipids in Health and Disease, 2008 Background Endeavors to manage obesity have been heavily reliant on controlling energy intake and expenditure equilibrium, but have failed to curtail the overweight and obesity epidemic. This dynamic equilibrium is more complex than originally postulated
Blum Kenneth +2 more
doaj +1 more source
In silico validation of microalgal metabolites against Diabetes mellitus
Сахарный диабет, 2017 Aim. Present study aimed to evaluate the efficiency of microalgal metabolites as ligands for anti-diabetic target proteins viz., glucokinase, fructose-1, 6-bisphosphatase, glycogen synthase kinase, cytochrome P450, multi drug resistant protein, and ...
Gurudeeban Selvaraj +3 more
doaj +1 more source